Condition
Primary Liver Cancer clinical trials and research
Research outlook What's coming for Liver cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 9 Primary Liver Cancer clinical trials that are recruiting, at sites in 14 countries (most in China (4), United States (4), Italy (2)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 14Countries
Newest Primary Liver Cancer clinical trials
All recruiting trials (9)
-
Plasma methylation test for detecting liver cancer recurrence (GNB4 and Riplet)
This test sees if a blood-based methylation assay measuring GNB4 and Riplet can detect return of primary liver cancer in people who had hepatectomy, liver transplant, ablation, or TACE.
-
Using contrast-enhanced ultrasound to check Y-90 radioembolization response in liver cancer
This will test whether contrast-enhanced ultrasound (CEUS) can show treatment response to Y‑90 radioembolization in people with newly diagnosed hepatocellular carcinoma who are scheduled for TARE.
-
Combining advanced ultrasound and molecular analyses to map tumor differences in liver cancer
This project tries combining multiple ultrasound techniques with molecular (multi-omics) tests to see if they can better characterize tumors and guide care for adults with primary liver cancer who are scheduled for surgery.
-
Combining portal and hepatic vein embolization for liver cancer treatment
This study is testing if combining two types of vein treatments can help more people with liver cancer have surgery and live longer.
-
Comparing two treatments for inoperable primary liver cancer
This study is testing which treatment works better for people with inoperable primary liver cancer by comparing stereotactic radiosurgery and radiofrequency ablation.
-
Evaluation of the HistoSonics Edison System for treating liver tumors
This study is testing how well the HistoSonics Edison System works for treating liver tumors and how different factors affect the treatment's success in real patients.
-
Evaluating a protein as a marker for liver cancer recurrence
This study is trying to see if higher levels of a certain protein in the blood can help predict if liver cancer will come back in people who have already had it.
-
Liquid biopsy to differentiate types of primary liver cancer
This study is testing a new blood test to see if it can tell the difference between two types of liver cancer, hepatocellular carcinoma and intrahepatic cholangiocarcinoma, to help doctors diagnose patients more safely.
-
Evaluating liver embolization techniques for tumor management
This study tests different liver embolization methods to see how well they help people with liver tumors live longer and maintain liver function while they continue their usual treatments.
Related topics
Quick answers
How many Primary Liver Cancer clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in China (4 trials), United States (4 trials), Italy (2 trials), Australia (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.